Publicaciones en las que colabora con María Angeles Rojo Rodríguez (5)

2018

  1. In vivo toxicity of the ribosome-inactivating lectin ebulin f in elderly mice

    Histology and Histopathology, Vol. 33, Núm. 9, pp. 979-986

2013

  1. In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours

    Cancer Immunology, Immunotherapy, Vol. 62, Núm. 3, pp. 541-551

2007

  1. Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b

    Cancer Letters, Vol. 256, Núm. 1, pp. 73-80

2005

  1. Specific dose-dependent damage of Lieberkühn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice

    Toxicology and Applied Pharmacology, Vol. 207, Núm. 2, pp. 138-146

2003

  1. Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 49, Núm. 4, pp. 537-545